Antiseptics and Disinfectant Market

The report "Antiseptics and Disinfectant Market by Type (Quaternary Ammonium Compounds), Product (Enzymatic Cleaners), Sales Channel (Fmcg, B2B), End Suer (Hospitals, Clinics), Region - Forecast to 2027", size is projected to reach USD 48.2 million by 2027 from USD 35.1 million in 2022, at a CAGR of 5.4% during the forecast period.

View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/antiseptics-and-disinfectant-market-128992252.html

Market is driven by factors such as global prevalence HAIs and the growing awareness for infection control, increase in post srrgical infections and rising advancements of antiseptics and disinfectants. On the other hand, an increase in chemical side effects of chemicals used in antiseptics and disinfectants is expected to limit market growth to a certain extent in the coming years. Upsurge in the cases of infections amongst global population is anticipated to drive the antiseptics and disinfectants market growth.

“The quaternary ammonium compunds accounted for the largest market share in the antiseptics and disinfectant market, type, during the forecast period”

The antiseptics and disinfectants market is segmented into quaternary ammonium coumpunds, chlorine compounds, alcohol / aldehyde, enzyme and others. In 2021, quaternary ammonium coumpunds accounted for a sizable market share. However, increase in HAIs is expected to increase significantly between 2021 and 2027. Upsurge in the cases of infectious diseases like COVID-19 amongst global population is anticipated to drive the antiseptics and disinfectants market growth.

“Medical device disinfectants segment accounted for the largest market share”

Based on product, the antiseptics and disinfectants market is segmented into enzymatic claners, medical device disinfectants and surface disinfectants. The medical device disinfectants segment accounted for the largest market share in 2021. This can be attributed to the rising number of stringernt regulations for infection control specially in healthcare facilities.

The B2B segment accounted for the largest share of the antiseptics and disinfectants market, by sales channel segment, in 2021

Based on sales channel, the antiseptics and disinfectants market is segmented into FMCG and B2B. The B2B segment accounted for the largest market share in 2021, mainly due to the rising awareness about household hygiene and requirement for disifection globally.

 The Hospitals segment accounted for the largest share of the antiseptics and disinfectants market, by end-user segment, in 2021

Based on end user, the antiseptics and disinfectants market is segmented into hospitals, clinics and others. In 2020, hospital settings accounted for a larger share of the antiseptics and disinfectants market, mainly due to the rising HAIs and other infectious diseases like COVID-19 and Influenza.

“APAC region accounted for the highest CAGR”

The global antiseptics and disinfectants market is divided into five regions: North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. According to the regional analysis, the Asia-Pacific region is likely to retain a significant market share in 2021 and the future. The Asia-Pacific antiseptics and disinfectants market is being propelled by an increase in the number of infectious diseases cases, increase in use of endoscope processes for surgery, increasing number of surgical cases, and rising government regulations for infection control. North America, on the other hand, will experience significant growth in the coming years due to the presence of key players.

The major players operating in this market are 3M (US), Reckitt Benckiser (UK), Steris PLC (US), Kimberly Clark Corporation (US), Bio-Cide International (US), Cardinal Health (US), Becton Dickinson and Company (US), Johnson & Johnson (US), Paul Hartmann AG (Germany) and Cantel Medical Corporation (US).

Don’t miss out on business opportunities in Antiseptics and Disinfectant Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com